fda removes semaglutide from drug shortage list february 21 2025 and Tirzepatide off list: What does this mean for weight loss access? Semaglutide's removal from the FDA

PlexusDx Personalized Approach to GLP-1 Safety PlexusDx compounds semaglutide and tirzepatide through licensed 503A pharmacies, enabling customized dosing protocols not available through commercial products like Wegovy or Mounjaro

Capsules are most popularly used for weight loss purposes

Common compounded concentrations are 2.5 mg/mL, 5 mg/mL, and 10 mg/mL

Gravity normally helps keep stomach contents down, and eliminating this advantage while the stomach remains full invites nighttime reflux

One study reported that Glutathione improved circulation, increasing the ability of study participants to walk pain-free for longer distances